loading

Mirum Pharmaceuticals Inc Azioni (MIRM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.48%
69.22
69.55 47.73 37.50 31.60
Operating Expenses
6.31%
95.69
102.14 72.87 61.77 58.75
Benefits Costs and Expenses
10.58%
93.88
104.99 71.06 111.22 61.53
Costs And Expenses
10.58%
93.88
104.99 71.06 111.22 61.53
Operating Income/Loss
18.77%
-26.47
-32.59 -25.15 -24.27 -27.15
Income/Loss From Continuing Operations Before Tax
30.42%
-24.66
-35.43 -23.34 -73.72 -29.93
Income Tax Expense/Benefit
177.33%
0.624
0.225 0.249 0.316 0.201
Income/Loss From Continuing Operations After Tax
29.11%
-25.28
-35.66 -23.59 -74.04 -30.13
Net Income/Loss
29.11%
-25.28
-35.66 -23.59 -74.04 -30.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,354%
46.93
1.9121 41.10 38.11 37.68
Diluted Average Shares
2,354%
46.93
1.9121 41.10 38.11 37.68
Basic Earnings Per Share
25.00%
-0.54
-0.72 -0.57 -1.94 -0.80
Diluted Earnings Per Share
25.00%
-0.54
-0.72 -0.57 -1.94 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):